Medizone deal

MZEI (New York) and Solwin Investments Ltd. formed Medizone New Zealand Ltd., a 50/50 joint venture responsible for regulatory approval and for licensing MZEI's technology in New Zealand and other areas. MZEI Medizone is an ozone-based treatment for diseases caused by lipid-enveloped viruses, including AIDS, hepatitis B and herpes. ...